Honestly don't know the answer, but how easy would it be for a Chinese lab to replicate Leronlimab, produce it, and sell it under a different name?? I would think it'd be really difficult to replicate.

Also, if we treated only ONE patient, I'm assuming CytoDyn would control the test??